Average Co-Inventor Count = 3.03
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurogen Corporation (13 from 305 patents)
2. N30 Pharmaceuticals, Inc. (9 from 17 patents)
3. Nivalis Therapeutics, Inc. (6 from 19 patents)
4. Other (1 from 832,891 patents)
5. The Mclean Hospital Corporation (1 from 123 patents)
30 patents:
1. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
2. 9717706 - Chromone inhibitors of S-nitrosoglutathione reductase
3. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
4. 9180119 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
5. 9138427 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
6. 9029402 - Pyrrole inhibitors of S-nitrosoglutathione reductase
7. 8957105 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
8. 8846736 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
9. 8691816 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
10. 8686015 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
11. 8673961 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
12. 8669381 - Chromone inhibitors of S-nitrosoglutathione reductase
13. 8642628 - Pyrrole inhibitors of S-nitrosoglutathione reductase
14. 8551986 - Treatment of sequelae of psychiatric disorders
15. 8481590 - Chromone inhibitors of S-nitrosoglutathione reductase